Analyst Price Target is $4.00
▲ +123.46% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Ampio Pharmaceuticals in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 123.46% upside from the last price of $1.79.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in Ampio Pharmaceuticals.
Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.